Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Genital Neoplasms, Male × Androgen Antagonists × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 4 Urogenital Neoplasms 1 Radiation Injuries 1 Prostatic Diseases 1 Genital Neoplasms, Male 1 Adenocarcinoma of the Prostate 1

Interventions

Abiraterone Acetate 2 onapristone 1 olaparib 1 abiraterone 1 Pluvicto 1 EPI-506 1 BAY 86-7548 1 Androgen Antagonists 1 Adrenal Cortex Hormones 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05067140 2025-03-17

A Study of ARV-766 Given by Mouth in Men With Metastatic Prostate Cancer

Novartis

Phase 1/2 Active not recruiting

Genital Neoplasms, Male, Prostatic Neoplasms, Urogenital Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡